中國人壽(02628.HK):一季度歸母淨利178.85億元 同比增長18%
格隆匯4月27日丨中國人壽(02628.HK)發佈公吿,2023年第一季度,實現營業收入人民幣3683.85億元,同比增長7.2%;歸屬於母公司股東的淨利潤178.85億元,同比增長18.0%;扣除非經常性損益後歸屬於母公司股東的淨利潤179.22億元,同比增長18.1%;基本與稀釋每股收益0.63元。
截至本報吿期末,公司總資產達人民幣54,625.86億元,投資資產達人民幣52,438.30億元。2023年第一季度,受投資收益變化及傳統險準備金折現率假設更新的影響,公司歸屬於母公司股東的淨利潤為人民幣178.85億元,同比增長18.0%。截至本報吿期末,核心償付能力充足率達147.53%,綜合償付能力充足率達210.19%,較2022年第四季度末分別上升3.94個百分點和3.41個百分點,償付能力持續保持較高水平,公司資本充足。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.